Freenome, Inc. - 8-K Filing

Freenome launches SimpleScreen™ Lung and offers combined lung and colorectal cancer screening in a single blood draw. (Items: 7.01 Regulation FD Disclosure On October 20, 2026, Freenome, Inc, 8.01 Other Events On October 20, 2026, the Company announced the launch of SimpleScreen™ Lung and a first-of-its-kind offering that enables eligib, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PCSC

Read the full article at SEC EDGAR

Part of the story Freenome, Inc. - 8-K Filing (3 articles)

More Regulatory news